Product image
InVivoMAb anti-mouse ICOS
BE0059
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse ICOS
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7E.17G9
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Wang W et al., 2018 Nov 12, Cancer CellRead more
- LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Bauche D et al., 2018 Aug 21, ImmunityRead more
- Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses. Liu D et al., 2016 Feb 1, J ImmunolRead more
- Parasite-Specific CD4+ IFN-gamma+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Villegas-Mendez A et al., 2016 Jan, Infect ImmunRead more
- Central memory CD8+ T lymphocytes mediate lung allograft acceptance. Krupnick AS et al., 2014 Mar, J Clin InvestRead more
- CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity. Rabant M et al., 2013 Nov, Am J TransplantRead more
- CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Charbonnier LM et al., 2012 Sep, Am J TransplantRead more
- CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. Kadri N et al., 2012 Apr 1, J ImmunolRead more